Clinical Trial Update: Brimonidine 0.1% Versus Brinzolamide 1% as Adjunctive Therapy to Latanoprost 0.005% [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing brimonidine 0.1% versus brinzolamide 1% as add-ons to latanoprost 0.005% for glaucoma and ocular hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Brimonidine 0.1% (brimonidine tartrate)
• Brinzolamide 1% (brinzolamide)
• Latanoprost 0.005% (latanoprost)

Snippet

Sponsor: Allergan | Conditions: Glaucoma, Ocular Hypertension | Phase 4 | Status: COMPLETED